<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Repro Medical Systems</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Tue, 21 Apr 2026 11:30:06 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>KORU Medical Systems/ Nasdaq up-listing</title>
<link>http://www.aktiencheck.de/forum/KORU_Medical_Systems_Nasdaq_up_listing-913004-t568541</link>
<guid>http://www.aktiencheck.de/forum/KORU_Medical_Systems_Nasdaq_up_listing-913004-t568541</guid>
<description>weitere Zulassungen von der FDA..., ...
https://www.korumedical.com/investors/news-events/press-releases/detail/106/koru-medical-systems-receives-fda-510k-clearance-for-the

Expansion on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.

Grifols ist ein Schwergewicht, verdammt gute News, dass die fortan die Devices von KRMD zur Verabreichung via SCIg nutzen werden. Grifols ist in über 100 Ländern weltweit aktiv unterwegs... [&lt;a href=&#034;http://www.aktiencheck.de/forum/KORU_Medical_Systems_Nasdaq_up_listing-913004-t568541&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







